TO
TOYWF
TOYO Co., Ltd
No data for this timeframe.
Vol
SEC Reports4
Recent Activity
May 18, 2026
SEC
TOYO Co., Ltd reported exceptional Q1 2026 results, with revenue surging 177% YoY to $142.8 million and net income reach
6-K — Impact 7/10
Apr 23, 2026
SEC
TOYO Co., Ltd entered into a sales agreement to offer up to $30 million in ordinary shares through an at-the-market (ATM
6-K — Impact 5/10
Apr 23, 2026
SEC
TOYO Co., Ltd is conducting an at-the-market equity offering of up to $30 million in ordinary shares through sales agent
424B5 — Impact 5/10
Latest Reports
BULLISH
6-K
7/10
TOYO Co., Ltd reported exceptional Q1 2026 results, with revenue surging 177% YoY to $142.8 million and net income reach
May 18, 2026
BEARISH
6-K
5/10
TOYO Co., Ltd entered into a sales agreement to offer up to $30 million in ordinary shares through an at-the-market (ATM
Apr 23, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 1 bullish, 2 bearish, 1 mixed, 0 neutral. Avg impact: 5.8/10.
BULLISH
6-K
7/10
TOYO Co., Ltd reported exceptional Q1 2026 results, with revenue surging 177% YoY to $142.8 million
May 18, 2026
BEARISH
6-K
5/10
TOYO Co., Ltd entered into a sales agreement to offer up to $30 million in ordinary shares through a
Apr 23, 2026
BEARISH
424B5
5/10
TOYO Co., Ltd is conducting an at-the-market equity offering of up to $30 million in ordinary shares
Apr 23, 2026
MIXED
20-F
6/10
TOYO Co., Ltd reported strong revenue growth of 142% year-over-year to $427.4 million in 2025, drive
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.2B | — | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.2B | — | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.8B | 94.8% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.1B | 32.9% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.